Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Trevidic

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Cosmetic Dermatology|May 2, 2023
Long-term efficacy and safety of a hyaluronic acid dermal filler based on Tri-Hyal technology on restoration of midface volumePhilippe Kestemont, Ferial Fanian, Philippe Garcia, et al.
Plastic and Reconstructive Surgery|October 7, 2015
Lower Face: Clinical Anatomy and Regional Approaches with Injectable FillersAndré Braz, Shannon Humphrey, Susan Weinkle, et al.
Journal of Drugs in Dermatology : JDD|December 5, 2013
Clinical equivalence of conventional OnabotulinumtoxinA (900 KDa) and IncobotulinumtoxinA (neurotoxin free from complexing proteins - 150 KDa): 2012 multidisciplinary French consensus in aestheticsBernard Poulain, Patrick Trevidic, Micheline Clave, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Cosmetic Dermatology|May 2, 2023
Long-term efficacy and safety of a hyaluronic acid dermal filler based on Tri-Hyal technology on restoration of midface volumePhilippe Kestemont, Ferial Fanian, Philippe Garcia, et al.
Plastic and Reconstructive Surgery|October 7, 2015
Lower Face: Clinical Anatomy and Regional Approaches with Injectable FillersAndré Braz, Shannon Humphrey, Susan Weinkle, et al.
Journal of Drugs in Dermatology : JDD|December 5, 2013
Clinical equivalence of conventional OnabotulinumtoxinA (900 KDa) and IncobotulinumtoxinA (neurotoxin free from complexing proteins - 150 KDa): 2012 multidisciplinary French consensus in aestheticsBernard Poulain, Patrick Trevidic, Micheline Clave, et al.
Pageof 3